CABA Live signals | Maximize Profits with Getagraph.com

SELL 157518 min ago

@ $23.86

Issued: 14 Feb 2024 @ 15:16

Return: -57.29%

Previous signal: Feb 14 - 10:40

Previous signal: Buy

Return: 0.08 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases...

Stats
Today's Volume	1.17M
Average Volume	1.15M
Market Cap	491.94M
EPS	$-0.510 ( 2024-05-16 )
Next earnings date	( $-0.550 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.96
ATR14	$0.0200 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Gerard Michael	Buy	100 000	Stock Option (Right to Buy)
2024-03-01	Chang David J.	Buy	130 000	Stock Option (Right to Buy)
2024-03-01	Nichtberger Steven	Buy	353 000	Stock Option (Right to Buy)
2024-03-01	Marda Anup	Buy	130 000	Stock Option (Right to Buy)
2024-03-01	Das Arun	Buy	100 000	Stock Option (Right to Buy)

INSIDER POWER
81.97
Last 97 transactions
Buy: 4 947 826 \| Sell: 1 979 584

Volume Correlation

Long: 0.38 (neutral)

Short: 0.29 (neutral)

Signal:(72.512) Neutral

Cabaletta Bio Inc Correlation

10 Most Positive Correlations
OZEM	1
DLHC	0.953
MPAA	0.95
APVO	0.945
MBIO	0.941
SHLS	0.938
RPTX	0.937
AZTA	0.933
QLGN	0.93
DMRC	0.93

10 Most Negative Correlations
JAN	-0.929
GERN	-0.926
VCTR	-0.923
PPTA	-0.917
GDST	-0.916
PPC	-0.915
IGLD	-0.915
RZLT	-0.915
AEYE	-0.911
GRIN	-0.91

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cabaletta Bio Inc Correlation - Currency/Commodity

0.50
( weak )

0.56
( weak )

0.00
( neutral )

0.54
( weak )

-0.19
( neutral )

Cabaletta Bio Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.43M (0.00 %)
EPS:	$-1.650

FY	2023
Revenue:	$0
Gross Profit:	$-1.43M (0.00 %)
EPS:	$-1.650

FY	2022
Revenue:	$0
Gross Profit:	$-3.68M (0.00 %)
EPS:	$-1.770

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.15

Financial Reports:

No articles found.

Cabaletta Bio Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cabaletta Bio Inc

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.